Skip to main content
Immuron hit with 44% first strike vote
Image for illustrative purposes only. Not a real photo.

Immuron hit with 44% first strike vote

By

Key points

  • Immuron has received a first strike, with 43.58% of votes cast against its 2026 remuneration report.
  • Shareholders also rejected an incentive plan renewal and a bid for more placement capacity.
  • Immuron faces a possible board spill vote if its remuneration report draws another strike at next year’s AGM.

Immuron (ASX:IMC) received a first strike at its AGM, with 43.58% of votes cast against its 2026 remuneration report.

The vote came after the CEO’s AGM presentation showed FY27 sales to October up 10% to A$3.0 million, although US sales fell 19%.

Shareholders also rejected the renewal of Immuron’s Omnibus Incentive Plan, with 50.99% of votes against.

A special resolution to increase the company’s placement capacity failed with 65.62% support, short of the 75% it needed.

A second strike at next year’s AGM would trigger a vote on whether to spill the board.

Following the announcement the Immuron share price was unchanged at $0.037.

Shareholders re-elected director Dr Jeannette Joughin with 33.83% of votes against, and rejected Param Lally, a candidate the board did not endorse, with 70.33% against.

Immuron is a biopharmaceutical company whose main product, Travelan, aims to reduce the risk of travellers’ diarrhoea and is sold in Australia, the US and Canada.


Frequently asked questions